Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomes
CELL REPORTS MEDICINE(2024)
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with enhanced transmissibility and immune escape have emerged periodically throughout the coronavirus disease 2019 (COVID-19) pandemic, but the impact of these variants on disease severity has remained unclear. In this single -center, retrospective cohort study, we examined the association between SARS-CoV-2 clade and patient outcome over a two-year period in Chicago, Illinois. Between March 2020 and March 2022, 14,252 residual diagnostic specimens were collected from SARS-CoV-2-positive inpatients and outpatients alongside linked clinical and demographic metadata, of which 2,114 were processed for viral whole-genome sequencing. When controlling for patient demographics and vaccination status, several viral clades were associated with risk for hospitalization, but this association was negated by the inclusion of population -level confounders, including case count, sampling bias, and shifting standards of care. These data highlight the importance of integrating non -virological factors into disease severity and outcome models for the accurate assessment of patient risk.
MoreTranslated text
Key words
SARS-CoV-2,molecular epidemiology,phylogenetics,viral evolution,genomic surveillance,variants of concern,COVID-19,severity modeling,confounders
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined